Tag: clinical trials

Posted on November 16, 2016

CRISPR GENE EDITING USED FOR FIRST TIME TO FIGHT LUNG CANCER: Raymond Rupert MD. MBA.

A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at […]

Posted on May 13, 2015

ADVOCACY FOR COMPLEX DRUG CLAIMS: Raymond Rupert MD. MBA. Rupert Case Management Inc.

TAKING PATIENT ASSISTANCE PROGRAMS TO THE NEXT LEVEL: Raymond Rupert MD. MBA. Rupert Case Management Inc. 800 620 7551 INTRODUCTION TO BIOLOGICS: Biologics change everything. Smart medications that target the source of the disease are the foundation for personalized medicine. The treatment outcomes can be outstanding. Unfortunately, these medications are expensive and this has lead […]

Posted on May 12, 2015

Tumour Vaccines: The Future Is Here- Raymond Rupert MD. MBA.

Something for patients and oncologists to consider in their future treatment plans. Vaxil Biotherapeutics has developed and is testing a cancer vaccine. Immucin is the vaccine. The vaccine is very innovative. It attacks the MUC1 marker on the tumour cell. About 90% of tumours have MUC1 markers. By attacking this marker, it makes the tumour […]

Posted on December 25, 2012

BIG TIME CHANGES FOR CLINICAL TRIALS:

The treatment of cancer is changing dramatically. The new drugs target a cancer gene fundamental to tumour growth. This is known as the molecular target. Many authorities see this as the start of the genetic age in cancer research and personalized cancer treatment. One big change is that clinical trials of new cancer drugs will […]